- Investing Ideas
- Global Pharmaceuticals & Biotech High ROE Growth Engines
Global Pharmaceuticals & Biotech High ROE Growth Engines
Results
64
64 companies
Incyte
Market Cap: US$24.5b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$120.77
7D
0.8%
1Y
40.7%
Exelixis
Market Cap: US$12.7b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$50.38
7D
-11.1%
1Y
30.9%
Orion Oyj
Market Cap: €11.0b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€79.90
7D
-2.1%
1Y
18.8%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥53.7b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥119.36
7D
7.8%
1Y
32.6%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥42.6b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥47.58
7D
11.5%
1Y
34.1%
Abbott India
Market Cap: ₹586.9b
Operates as a pharmaceutical company in India.
500488
₹27,617.45
7D
-1.0%
1Y
-16.9%
3SBio
Market Cap: HK$44.3b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$17.78
7D
3.5%
1Y
-44.4%
ACADIA Pharmaceuticals
Market Cap: US$5.1b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$29.45
7D
2.3%
1Y
17.2%
SK Biopharmaceuticals
Market Cap: ₩6.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩87,600.00
7D
4.9%
1Y
-12.9%
Ajanta Pharma
Market Cap: ₹451.4b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,614.60
7D
4.2%
1Y
34.6%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹451.4b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,664.65
7D
3.3%
1Y
-3.8%
Suzhou Zelgen Biopharmaceuticals
Market Cap: CN¥31.8b
Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.
688266
CN¥120.22
7D
7.1%
1Y
6.9%
Sumitomo Pharma
Market Cap: JP¥611.2b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,362.50
7D
6.2%
1Y
1.0%
Xiamen Amoytop Biotech
Market Cap: CN¥25.1b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥61.43
7D
12.6%
1Y
-28.2%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥24.6b
Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.
600329
CN¥36.79
7D
-0.2%
1Y
-17.8%
Zealand Pharma
Market Cap: DKK 23.1b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 340.70
7D
3.8%
1Y
-2.8%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.15
7D
-0.8%
1Y
3.7%
Neuland Laboratories
Market Cap: ₹297.9b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹23,222.15
7D
8.0%
1Y
75.1%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س9.9b
Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.
4015
ر.س142.00
7D
1.4%
1Y
-12.7%
CareDx
Market Cap: US$2.4b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$47.31
7D
4.0%
1Y
290.0%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥15.0b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥42.07
7D
2.9%
1Y
-1.6%
ADMA Biologics
Market Cap: US$2.2b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$9.78
7D
5.6%
1Y
-43.1%
HBM Holdings
Market Cap: HK$13.7b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$15.81
7D
24.2%
1Y
36.9%
Innoviva
Market Cap: US$1.5b
Operates as a biopharmaceutical company in the United States and internationally.
INVA
US$20.81
7D
1.5%
1Y
1.0%
CORONA Remedies
Market Cap: ₹129.2b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹2,113.20
7D
3.3%
1Y
n/a
ChemoMetec
Market Cap: DKK 8.1b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 476.60
7D
14.8%
1Y
-5.7%
BioGaia
Market Cap: SEK 11.3b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 113.10
7D
1.3%
1Y
19.0%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,300.00
7D
8.3%
1Y
11.0%
Soho Global Health
Market Cap: Rp14.8t
Together with its subsidiaires, operates as a healthcare company in Indonesia.
SOHO
Rp1,165.00
7D
-3.3%
1Y
59.6%
Zevra Therapeutics
Market Cap: US$673.4m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.44
7D
8.6%
1Y
21.3%
CorMedix
Market Cap: US$572.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.10
7D
-4.2%
1Y
-41.2%
Middle East Pharmaceutical Industries
Market Cap: ر.س2.1b
Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.
4016
ر.س60.50
7D
-0.3%
1Y
-14.0%
Onconic Therapeutics
Market Cap: ₩702.9b
Engages in the research and development of anti-cancer therapy in South Korea.
A476060
₩15,480.00
7D
-2.9%
1Y
150.2%
Rafa Laboratories
Market Cap: ₪1.4b
A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.
RAFA
₪14.69
7D
-7.7%
1Y
n/a
DHG Pharmaceutical
Market Cap: ₫12.4t
Engages in the manufacture and sale of pharmaceutical products in Vietnam.
DHG
₫94,900.00
7D
0.1%
1Y
-7.4%
Q32 Bio
Market Cap: US$458.7m
A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.
QTTB
US$15.37
7D
-6.8%
1Y
749.2%